Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma Response and Biology-Based Risk factor-guided therapy in treating younger patients with non-high Neuroblastoma

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Non-high-risk Neuroblastoma
  • Age: Between 0 years - 18 years
  • Gender: Male or Female
  • Other Inclusion Criteria:

    1. Patients must be < 12 months (< 365 days) of age at diagnosis with INRG Stage L1; or < 18 months (< 547 days) of age at diagnosis with INRG Stage L2 or Stage Ms neuroblastoma/ganglioneuroblastoma.


    2. Patients must have newly diagnosed MYCN non-amplified neuroblastoma (ICD-O morphology 9500/3) or MYCN non-amplified ganglioneuroblastoma verified by histology.


    3. No prior radiotherapy or chemotherapy, with the exception of dexamethasone

You may not be eligible for this study if the following are true:

  • 1.  Patients with MYCN amplified tumors are not eligible

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.